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Edited by Robert BaroukiAbstract The adipocyte-secreted hormone leptin participates in
the regulation of hematopoiesis and enhances proliferation of
hematopoietic cells. We used an adaptation of the MAPPIT
mammalian two-hybrid method to study leptin signalling in a
hematopoietic setting. We conﬁrmed the known interactions of
suppressor of cytokine signalling 3 (SOCS3) and STAT5 with
the Y985 and Y1077 motifs of the leptin receptor, respectively.
We also provide evidence for novel interactions at the Y1077 mo-
tif, including phospholipase C gamma and several members of
the SOCS protein family, further underscoring the important
role of the Y1077 motif in leptin signalling.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Leptins’ role has been studied most extensively in the central
nervous system, where it regulates food intake and energy bal-
ance. Recent research revealed a wider spectrum of biological
actions of this adipokine in other vital processes. Leptin-deﬁ-
cient (ob/ob) and leptin-receptor (LR)-deﬁcient (db/db) mice
develop a complex syndrome characterized not only by obesity
but also abnormal reproduction, hormonal imbalances and
dysregulation of the hematopoietic and immune system [1]. Al-
tered amounts of lymphopoietic progenitors, circulating lym-
phocytes, and leukocytes are observed in ob/ob and db/db
mice, and correlation studies between plasma leptin concentra-
tion and leukocyte counts in humans led to the notion that lep-
tin participates in the regulation of hematopoiesis [2–4]. In line
with this, expression of the signalling-competent leptin receptor
long isoform (LRlo) is observed in fetal liver, bone marrow,
CD34+ progenitor cells as well as in several hematopoietic cell
lines, such as TF1 and MO7E [5,6].
The LR, a member of the class I cytokine receptor family, is
expressed as multiple alternatively spliced isoforms, of whichAbbreviations: LR, leptin receptor; SOCS, suppressor of cytokine si-
gnalling; CIS, cytokine inducible SH2 containing protein; STAT, sig-
nal transducer and activator of transcription; PLCc, phospholipase C
gamma
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doi:10.1016/j.febslet.2006.04.094only the LRlo can activate the JAK-STAT signalling pathway
[7]. This LRlo form has three conserved tyrosine (Y) motifs in
the intracellular domain, being Y985, Y1077 and Y1138 in the
mouse LR. These sites become phosphorylated upon leptin
treatment and are used as docking sites for several signalling
or inhibitory molecules. Examples include recruitment of
STAT3 (signalling transducer and activator of transcription)
via the Y1138 motif of the LR, STAT5 via the Y1077 and
Y1138 motif of the LR [8] and binding of the SH2-containing
phosphatase SHP-2 on the Y985 motif leading to activation of
the Ras-MAPK pathway [9]. In addition, several members of
the SOCS (suppressor of cytokine signalling) protein family
can interact with the LR. SOCS3 associates predominantly
with the pY985 motif [10,11] and was identiﬁed as a potent
inhibitor of LR signalling. SOCS2 interacts with Y1077 and
cytokine inducible SH2 containing protein (CIS) with both
Y985 and Y1077 motifs (Lavens et al., in press).
In this report, we used the human premyeloid TF1 and the
murine Ba/F3 pro-B cell lines asmodels to study protein interac-
tions with the LR in a hematopoietic environment. To this end,
we adapted the MAPPIT (mammalian protein–protein interac-
tion trap) method [12] to operate in hematopoietic cell types.2. Materials and methods
2.1. Constructs
Generation of the mutant mouse LR(YYF) in the pMET7
expression vector was described elsewhere [13]. Construction of the
pSEL-60GGS-mLR-Y985 and pSEL-60GGS-mLR-Y1077 baits was
described in Lavens et al. (in press). A fragment of the intracellular
part of the hbc receptor, containing 4 tyrosine motifs, was ampliﬁed
by PCR on the pSV532-hbc plasmid using primer 1 and primer 2
(see Table 1). The PCR fragment was digested with ApoI and was li-
gated into the pMG2-SVT plasmid [12] which was digested with EcoRI
leading to replacement of the gp130 part of the pMG2-construct. This
prey-construct was called pMbc-SVT. This construct was further di-
gested with EcoRI and NotI, allowing exchange of the SVT part by
a full-length rat SOCS3 F25A PCR fragment (primers 3 and 4). The
KIR domain of SOCS3 was rendered inactive by a F25A mutation that
was introduced using primers 5 and 6. All other members of the SOCS
family were cloned as pMbc-prey fusion proteins. Murine CIS and
SOCS2 were already cloned as pMG2-preys [14], and were transferred
as EcoRI–XbaI fragments. Murine SOCS1 was ampliﬁed by PCR
using primers 7 and 8 and was ligated into EcoRI–NotI opened pMbc
vector. Inactivation of the KIR domain of SOCS1 was done with prim-
ers 9 and 10 leading to a F59A mutation. The pMbc-mSOCS4 con-
struct was obtained by PCR on cDNA prepared from mouse thymus
(gift from Dr. Peter Brouckaert) with primers 11 and 12 and insertion
in the EcoRI–NotI opened pMbc vector. The pMbc-mSOCS5 and
-mSOCS6 prey constructs were generated by ampliﬁcation from theblished by Elsevier B.V. All rights reserved.
Table 1
Overview of primers used in this study
Primer 1 Forward 5 0-CGCAAATTTTCCCACACACCTGAGAAACA
Primer 2 Reverse 5 0-CGCGAATTCAGGATTGTTCCTTGGTGACC
Primer 3 Forward 5 0-GCGAGATCTCAGAATTCGTCACCCACAGCAAGTTTCC
Primer 4 Reverse 5 0-GGTGCGGCCGCTCCACCGGTCGACGAAAGTGGAGCATCATACTGG
Primer 5 Forward 5 0-CGCCTCAAGACCGCTAGCTCCAAGAGC
Primer 6 Reverse 5 0-GCTCTTGGAGCTAGCGGTCTTGAGGCG
Primer 7 Forward 5 0-CCAGCGAATTCATGGCGCGCCAGGACTACAAGGAC
Primer 8 Reverse 5 0-GCTTGCGGCCGCTTAGATCTGGAAGGGGAAGGA
Primer 9 Forward 5 0-CACTTCCGCACCGCGCGCTCCCACTCC
Primer 10 Reverse 5 0-GGAGTGGGAGCGCGCGGTGCGGAAGTG
Primer 11 Forward 5 0-GCGGAATTCGCTGAAAACAATAGT
Primer 12 Reverse 5 0-CGCGCGGCCGCTCACTGCTGCTCTGGCA
Primer 13 Forward 5 0-GCGGAATTCGATAAAGTGGGGAAAATGTG
Primer 14 Reverse 5 0-CGCGCGGCCGCTTACTTTGCTTTGACTG
Primer 15 Forward 5 0-GCGGAATTCAAGAAAATCAGTCTG
Primer 16 Reverse 5 0-CGCGCGGCCGCTCAGTAGTGCTTCTCC
Primer 17 Forward 5 0-GCGGAATTCGTGTTCCGCAACGTG
Primer 18 Reverse 5 0-CGCTCTAGAGACTACGTGGAAGGCTCCA
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E0635 D6 (mSOCS6) using, respectively, primers 13 and 14, and 15
and 16, again allowing insertion in the EcoRI–NotI opened pMbc vec-
tor. A splice variant lacking exon 4 of murine SOCS7 (Dr. Martens N,
personal communication) was ampliﬁed by PCRwith primers 17 and 18
on cDNA of mouse hypothalamic N-38 cells (gift from Dr. Belsham)
and inserted in the EcoRI–XbaI opened pMbc vector. pMbc-prey vec-
tors carrying hPLCc(2· SH2) and hSTAT5a(F694) were obtained by
EcoRI–XbaI insert swaps from the parental pMG2-based vectors
[14]. The hPLCc(2· SH2) insert was also cloned in the pMET7-expres-
sion vector [13] by exchanging EcoRI–XbaI digested inserts.
2.2. Cell lines, electroporation conditions, reporter assays, expression
analysis and phospho-peptide aﬃnity chromatography
Culture conditions for Hek293T cells were as described [11]. The
TF1-M1-16 cell line is a hIL5-responsive derivative of TF1 cells [15]
[16]. Cells were grown in RPMI medium supplemented with 10% fetal
calf serum and 1 ng/ml hIL5. Ba/F3 cells were grown in RPMI medium
supplemented with 10% fetal calf serum and 1 ng/ml mIL3 (Biogen).
Transfections of both cell lines were done by electroporation (300 V,
1500 lF). Cells were simultaneously starved (removal of serum and
hIL5 or mIL3) for 24 h and stimulated with 5 ng/ml hEpo or 100 ng/
ml leptin. Activation of the pGL2-SPI2.1-luciferase reporter (gift by
Dr. Walter Becker [17]) was measured as described before [14]. All
MAPPIT data in this manuscript are expressed as fold induction (stim-
ulated/non-stimulated or NS) and are representative of at least three
independent experiments.
Expression analysis of the FLAG-tagged bc-fusion proteins was done
by Western blot analysis with anti-FLAG mouse monoclonal antibody
(Sigma), using lysates of electroporated cells. Expression of the GGS
baits was veriﬁed using goat anti-human EpoR polyclonal IgG (R&D
Systems) at 2 lg/ml and Alexa 488-conjugated donkey anti-goat IgG
(Molecular Probes) at 4 lg/ml. Fluorescence-activated cell sorting
(FACS) was performed on a FACSCalibur (Becton Dickinson).
Phospho-peptide aﬃnity chromatography experiments were per-
formed using the biotin-QRQPSVK(P)Y985ATLVSNDK and biotin-
NHREKSVC(P)Y1077LGVTSVNR peptides and lysates from Hek293T
cells transfected with the pMET7-PLCc(2· SH2) expression plasmid as
described in Lavens et al. (in press).3. Results
3.1. bc-MAPPIT: design and proof of principle
The MAPPIT concept is based on JAK-STAT signalling and
is shown in Fig. 1. We here designed a variant of the MAPPIT
method that enables us to detect protein interactions in hema-
topoietic cells. Since cytokines predominantly activate STAT5
in hematopoietic cells, we designed novel prey constructs,wherein the gp130 moiety is swapped for a part of the bc-
receptor, containing several STAT5 interaction sites. In the
MAPPIT bait constructs, we replaced the cytosolic domain
of the LR following the JAK2 interaction site, by a large array
of Gly-Gly-Ser (GGS) repeats (Fig. 1B) in order to prevent any
background prey association with the LR-F3 (Lavens et al., in
press). Interaction of co-transfected GGS-bait and bc-prey will
lead in this setting to activation of the STAT5-dependent
SPI2.1-luciferase reporter. The MAPPIT technique also allows
the analysis of interactions with the LR itself. A mutant
LR(YYF) [13] was used to avoid possible background by acti-
vation of STAT3 and 5 via Y1138 (Fig. 1C). Binding of
STAT5 to the Y1077 motif [18], did not interfere with the
read-out in the hematopoietic cell systems used.
We initially tested the concept using a SOCS3(F25A)-prey.
SOCS3 strongly binds to the LR pY985-motif and negatively
regulates LR signalling [18]. To suppress its inhibitory eﬀect
on JAK2 activation, we inactivated the Kinase Inhibitory Re-
gion (KIR domain) in the SOCS3 prey by introducing a F25A
mutation. SV40 large T protein (SVT) was used as negative
prey control. As shown in Fig. 2, clear, speciﬁc signals were
obtained in both Ba/F3 and TF1-M1-16 cells with either the
LR(YYF) lacking the Y1138 STAT recruitment motif or with
a GGS-bait construct containing only the LR Y985 motif. A
slight activation was observed in case of the negative control
in Ba/F3 cells, when stimulated with leptin and in TF1-M1-
16 cells when stimulated with Epo. This is probably due to
the presence of the endogenous LR or EpoR on Ba/F3 and
TF1-M1-16 cells, respectively. The data shown in Figs. 2 and
3A are corrected for this low background. In these, and the
experiments described below, expression of the FLAG-tagged
bc-preys in TF1-M1-16 or Hek293-T cells was revealed by
immunoblotting using an anti-FLAG antibody (data not
shown). Expression analysis of the GGS baits in TF1-M1-16
cells was performed using FACS analysis with antibodies
against the extracellular domain of the EpoR as described
before [18] (data not shown).3.2. Interaction of signalling molecules with the LR
Since the LR can trigger several signalling pathways, we next
checked interaction of distinct signalling molecules with the
LR(YYF) in both Ba/F3 and TF1-M1-16 cells. The bc-preys
Fig. 1. (A) MAPPIT principle: A bait protein is C-terminally linked to a chimeric receptor consisting of the extracellular part of the EpoR and the
transmembrane and intracellular parts of a STAT3 recruitment-deﬁcient LRF3, while the prey protein is fused to functional STAT3 recruitment sites
of gp130. Co-expression of interacting bait and prey can lead to functional complementation of STAT3 activity that can be measured with a STAT3-
responsive luciferase reporter. (B) GGS-MAPPIT: A bait protein is attached C-terminally to a variant of the chimeric EpoR-LR receptor. The
cytosolic domain of the LR following the JAK2 association domain is replaced by a GGS-array, preventing any background activation due to prey
association with the LR-F3. In this paper we use a bc-receptor based prey construct (inset). The bc receptor contains six tyrosine motifs in its
cytoplasmatic tail of which three are known STAT5 recruitment sites. A prey in the bc-MAPPIT concept is fused to a part of the bc receptor
containing all three STAT5 recruitment sites. (C) LR MAPPIT: Here, the LR itself functions as bait protein. Due to the Y1138F mutation, no
detectable STAT recruitment occurs in our hematopoietic cell types. Upon stimulation, the two membrane proximal tyrosines become
phosphorylated by JAK2. Interaction of the bc-based prey protein with the LR allows eﬃcient STAT5 activation and subsequent reporter induction.
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encompassing its two SH2-domains. The STAT5a prey was
made signalling-deﬁcient by introducing an Y694F mutation.Strong luciferase signals were detected with the PLCc-prey,
and a weaker interaction was seen with the STAT5a-prey
(Fig. 3A). Analysis using the GGS-LR Y985 and GGS-LR
Fig. 2. bc-MAPPIT: proof of principle. (Bars 1–4) Ba/F3 cells were transiently electroporated with plasmids encoding the non-speciﬁc prey bc-SVT
used as negative control, and the speciﬁc prey bc-SOCS3F25A with, respectively, the LR(YYF) mutant (Bars 1 and 2) or the EpoR-LR-60xGGS-
Y985 bait (Bars 3 and 4), combined with the pGL2-SPI2.1-luciferase reporter. After 48 h of electroporation, the cells were either stimulated overnight
with leptin/Epo as indicated or were left untreated. Data are expressed as fold induction (stimulated/NS). (Bars 5–8) Similar experimental set-up as
above, but performed in TF1-M1-16 cells. The values obtained with the bc-SVT prey in Ba/F3 cells, when stimulated with leptin and in TF1-M1-16
cells when stimulated with Epo were, respectively, 5- and 2-fold, possibly due to endogenous expression of the LR and EpoR. The values shown are
normalized for this background.
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Y1077 motif (Fig. 3B). We conﬁrmed the PLCc dataset with
(phospho)peptide aﬃnity chromatography using lysates from
Hek293T cells containing a FLAG-tagged PLCc-derived poly-
peptide encompassing both SH2 domains. Clear binding was
observed with the pY1077 phospho-peptide, with only minor
binding to the pY985 motif. No detectable binding was ob-
served with the non-phosphorylated peptides (Fig. 4B).
3.3. Interaction map of SOCS proteins with the LR
To determine their interaction with the LR, all members of
the SOCS family were cloned as bc-preys and were tested for
interaction with LR(YYF) in Ba/F3 or TF1-M1-16 cells
(Fig. 4A and B). The inhibitory eﬀect by SOCS1 was sup-
pressed by a F59A mutation in its KIR domain, similar to
SOCS3 (see above). In Ba/F3 cells, clear induction of lucifer-
ase activity indicated that CIS, SOCS2 and SOCS3 interact
with the LR(YYF), consistent previous reports [11] (Lavens
et al., in press). In addition, reproducible induction of lucifer-
ase activity was also seen with SOCS6 and SOCS7. Similar re-
sults were obtained in TF1-M1-16 cells. No signal was
obtained in the case of the bc-SOCS1 F59A, SOCS4 and
SOCS5 preys.
A detailed binding analysis of SOCS preys showed that
SOCS3 interacted with the Y985 motif, while SOCS2 and -6
bind to the Y1077 motif. CIS and SOCS7 can interact with
both motifs (Fig. 4C). These bc-preys bind speciﬁcally with
the tyrosine motifs of the LR, since no interaction could be
found with an irrelevant GGS-FKBP12 bait and replacement
of preys by a wild-type SOCS protein (SOCS7) did not lead
to luciferase activity (data not shown).4. Discussion
Although a role of leptin in hematopoiesis is now well doc-
umented, studies on the intracellular pathways used by the LRin hematopoietic cells are limited. Leptin can prevent apopto-
sis of leukaemia cells through STAT3 and mitogen-activated
protein kinase (MAPK) phosphorylation [19] and activation
of the MAPK and PI3-K pathways by leptin has been shown
in peripheral blood mononuclear cells [20]. Here, we adapted
the MAPPIT mammalian two-hybrid method to a hematopoi-
etic setting and studied protein interactions with the LR in
TF1-M1-16 and Ba/F3 cells. The basic MAPPIT set-up using
STAT3 did not function in these cell lines, presumably due
to low amounts of endogenous STAT3. We therefore swapped
the gp130 moiety in the prey constructs for part of the cyto-
solic domain of bc capable of recruiting and activating STAT5,
which is highly expressed in hematopoietic cell types. Our
experiments illustrate the ﬂexibility of the MAPPIT strategy,
which can be adapted to operate in diﬀerent types of human
cells by simple adjustment to diﬀerent reporter systems.
The murine LR cytoplasmic tail contains three conserved
tyrosine motifs at positions Y985, Y1077 and Y1138. With
the bc-MAPPIT approach we conﬁrmed the interaction of
SOCS3 with the LR Y985 motif in hematopoietic cells, whilst
only a very weak eﬀect was seen with Y1077, consistent with
the weak interaction with this motif (Figs. 2 and 4C) (10).
The role of the Y1077 motif in leptin signalling is still some-
what controversial since its tyrosine phosphorylation is diﬃ-
cult to demonstrate. However, the Y1077 motif was shown
to interact with SOCS3 and STAT5 in a phosphorylation-
dependent modus [8,11]. Here, we provide further evidence
for an important role of the Y1077 motif in leptin signalling
with several additional signalling proteins interacting at this
site. Although there is evidence suggesting involvement of
the phospholipase C–phosphokinase C (PLC–PKC) pathway
in leptin signalling [21–23], no proof for interaction of PLC
proteins with the LR was obtained so far. We here show that
PLCc can interact via its SH2 domains with the LR(YYF) and
more detailed analysis using both bc-MAPPIT and peptide
aﬃnity chromatography revealed that PLCc interacts with
the phosphorylated Y1077 motif.
Fig. 3. Interaction of STAT5 and PLCc with the LR. (A) Ba/F3 (Bars 1–3) or TF1-M1-16 cells (Bars 4–6) were transiently electroporated with
plasmids encoding pMet7-LR(YYF) and a bc-prey as indicated or an empty vector, combined with the pGL2-SPI2.1-luciferase reporter.
Experimental set-up was as in Fig. 2. The values were normalized for background as mentioned in Fig. 2. (B) Ba/F3 were transiently electroporated
with plasmids encoding the pSEL60GGS-LR Y985 or pSEL-60GGS-LR Y1077 bait and a bc-prey as indicated or an empty vector, combined with
the pGL2-SPI2.1-luciferase reporter. Experimental set-up was as in Fig. 2. (C) The FLAG-tagged PLCc(2· SH2) protein was expressed in Hek293T
cells and total cell lysates were incubated with biotinylated peptides encompassing the LR (phosphorylated) Y1077 or Y985 motifs. Immunoblotting
with anti-FLAG antibody revealed speciﬁc interaction of PLCc with the phosphorylated Y1077 motif.
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nalling in diﬀerent ways [24], we performed a MAPPIT scan to
monitor the binding capacity of all SOCS proteins with the LR.
We were able to detect binding of SOCS3 as expected, but also
of CIS, SOCS2, SOCS6 and SOCS7. SOCS4- and SOCS5-preys
do not induce reporter activity, indicating that no interaction
occurs, although direct inhibition of STAT5 activation cannot
be completely ruled out. Also, no interaction of SOCS1 is de-tected, which is somewhat surprising since SOCS1 is known
to bind JAK2 [25] and can inhibit leptin signalling in cell-based
assays (Piessevaux et al., submitted for publication). Possibly,
certain preys that directly interact with JAK2 may be subject
to a topological restraint whereby phosphorylation of the prey
tyrosines by the JAK is sterically impossible. Interestingly, the
closely related SOCS proteins CIS and SOCS2 both bind to the
Y1077 motif, but only CIS appears to interact with the Y985
Fig. 4. Interaction of SOCS proteins with the LR. (A, B) Ba/F3 (Panel A) or TF1-M1-16 cells (Panel B) were transiently electroporated with
plasmids encoding pMet7-LR(YYF) and a bc-SOCS prey or an empty vector, combined with the pGL2-SPI2.1-luciferase reporter. Experimental set-
up was as in Fig. 2. (C) Ba/F3 cells were transiently electroporated with plasmids encoding the pSEL60GGS-LR Y985 or pSEL-60GGS-LR Y1077
bait and a bc-SOCS prey as indicated or an empty vector, combined with the pGL2-SPI2.1-luciferase reporter. Experimental set-up was as in Fig. 2.
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types (Lavens et al., in press). Similarly, SOCS7 can interact
with both the Y985 and the Y1077 motifs, whilst SOCS6 only
binds Y1077. Inhibition or binding of SOCS6 on the LR has
not been reported so far, although both can be expressed in
hematopoietic cells [26]. Inhibition of leptin signalling by
SOCS7 has been shown through binding and inhibition of
STAT3 by SOCS7 [24]. However, binding of SOCS7 on the
LR itself was not demonstrated before. Our ﬁndings suggestthat besides the well-established inhibitory eﬀect of SOCS3
on hypothalamic leptin signalling, other SOCS proteins can
bind to the LR and possibly may modulate leptin signalling
in other, e.g., peripheral cell types.
Together, our ﬁndings illustrate that the MAPPIT strategy
can easily be adapted to hematopoietic cell types. Our ﬁndings
identify several novel interactions with the LR and provide a
rationale for more detailed functional analysis of leptin signal-
ling in hematopoiesis.
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